Sara Biela and Chase Turner, graduate students from Sullivan University College of Pharmacy in Kentucky, presented new findings tied to industrial hemp derived CBD’s anti-cancer properties at the American Society for Biochemistry and Molecular Biology held back on April 21-25.
The two new studies investigated the potential for Cannabidiol (CBD) derived from a variety of hemp plant known as KY-hemp, grown and produced in Kentucky. Development of the new strain involved carefully growing the industrial hemp in an controlled environment in order to eliminate any residual contaminates that could possibly effect the therapeutic properties of the CBD that was extracted.
The first study researchers found that by adding a variety of different CBD doses to ovarian cells led to a slowing of cell migration, or metastasis. This would reduce the spread of cancer cells to other parts of the body. The second study, showed that the Ky-hemp variety slowed the “secretion of interleukin IL-1beta, which has been linked to slowing the ovarian cancer from spreading so quickly.
“Our findings from this research as well as prior research show that KY hemp slows ovarian cancer comparable to or even better than the current ovarian cancer drug Cisplatin,” said Turner. “Since Cisplatin exhibits high toxicity, we anticipate that hemp would carry less side effects. However, that needed to be tested in the future.
You may be interested
Canopy River Begins Trading on the Toronto Stock Exchange (TSX)Editor - September 21, 2018
Yesterday, Canopy Rivers Inc. (TSXV:RIV) announced that their company has began trading on the TSX Venture Exchange under the ticker symbol RIV. The company works in conjunction with…
Aurora Cannabis in Discussions with Coca-Cola to Produce CBD Infused BeveragesEditor - September 20, 2018
In a press release this week, Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) confirmed that it has entered into the beginning stages of negotiations with beverage conglomerate Coca-Cola to…
Australian CBD Company Elixinol Begins Trading on OTCQXEditor - September 19, 2018
Yesterday, international hemp-derived CBD company Elixinol (ASX: EXL) began trading on the OTCQX, a U.S. based stock market exchange, under the ticker symbol ELLXF. The company is…